Valley Medical Pharmacy 
630 Main Street 
Brawley, CA 92227 
eRx ID#0585957 
1 (800) 322-0808 | Toll Free Fax: 1 (855) 322-0808 
Email: drugsdepot@yahoo.com 
Web: www.drugsdepot 
Timing: Monday to Friday | 9:00 AM to 5:45 PM 


Flavoxate Hcl 100 Mg Tabs 100 By Perrigo Pharma

Image 0 of Flavoxate Hcl 100 Mg Tabs 100 By Perrigo PharmaImage 1 of Flavoxate Hcl 100 Mg Tabs 100 By Perrigo Pharma

Flavoxate Hcl 100 Mg Tabs 100 By Perrigo Pharma

Call for Price

Flavoxate Hcl 100 Mg Tabs 100 By Perrigo Pharma This Item Requires A Valid Order From A Physician Licensed in USA. Item Number.:RXD3634979/RXB10029339
Size : 100
Selling UoM : EA
NDC: 00574-0115-01
UPC Barcode : 305740115015
Supplier: 0050001922 PERRIGO CO
Supplier Material : 011501
Generic Code : 004927 FLAVOXATE HCL ORAL TABLET 100 MG
Fine Line Class : 850085008510 All Rx Products
Product Category : RX Pharmaceuticals
Product Type : GRX Generic RX

Have a question?

  Call for Price

Product Description.:

PAD 0115
tablet , film-coated , white , round round
Debossed

Urispas (flavoxate HCl) tablets contain flavoxate hydrochloride, a synthetic urinary tract spasmolytic.

Chemically, flavoxate hydrochloride is 2-piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate hydrochloride.

Urispas is supplied in tablets for oral administration. Each round, white, film-coated Urispas tablet is debossed URISPAS SKF and contains flavoxate hydrochloride, 100 mg. Inactive ingredients consist of calcium phosphate, castor oil, cellulose acetate phthalate, magnesium stearate, polyethylene glycol, starch and talc.

INDICATIONS

Urispas (flavoxate HCl) is indicated for symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis. Urispas is not indicated for definitive treatment, but is compatible with drugs used for, the treatment of urinary tract infections.
DOSAGE AND ADMINISTRATION

Adults and children over 12 years of age: One or two 100 mg tablets 3 or 4 times a day. With improvement of symptoms, the dose may be reduced. This drug cannot be recommended for infants and children under 12 years of age because safety and efficacy have not been demonstrated in this age group.

SIDE EFFECTS

The following adverse reactions have been observed, but there are not enough data to support an estimate of their frequency.

Gastrointestinal: Nausea, vomiting, dry mouth.

CNS: Vertigo, headache, mental confusion, especially in the elderly, drowsiness, nervousness.

Hematologic: Leukopenia (one case which was reversible upon discontinuation of the drug).

Cardiovascular: Tachycardia and palpitation.

Allergic: Urticaria and other dermatoses, eosinophilia and hyperpyrexia.

Ophthalmic: Increased ocular tension, blurred vision, disturbance in eye accommodation.

Renal: Dysuria.